Photodynamic therapy for acute central serous chorioretinopathy: The safe effective lowest dose of verteporfin

Retina

Volumn 29, Issue 8, 2009, Pages 1155-1161

  Zhao, Ming Wei ^a   Zhou, Peng ^a   Xiao, Hong Xiang ^a   Lv, Yong Shun ^a   Li, Chun An ^a   Liu, Guo Dong ^a   Li, Xiao Xin ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Acute central serous chorioretinopathy; Dose of verteporfin; Photodynamic therapy

Indexed keywords

VERTEPORFIN;

ACUTE CENTRAL SEROUS CHORIORETINOPATHY; ADULT; AGED; ARTICLE; CHORIORETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; RETINA DISEASE; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY;

ACUTE DISEASE; ADULT; AGED; CENTRAL SEROUS CHORIORETINOPATHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINA; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 70349153098     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181a6c028     Document Type: Article

References (20)

1. Klais CM, Ober MD, Ciardella AP, Yannuzzi LA. Central serous chorioretinopathy. In: Hinton DR, Schachat AP, Wilkinson CP, Ryan SJ, eds. Retina. 4th ed. London: Elsevier; 1135-1161, 2006.
2. Spaide RF, Campeas L, Haas A, et al. Central serous chori-oretinopathy in younger and older adults. Ophthalmology 1996;103:2070 -2079; discussion: 2079-2080.
3. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-1458.
4. Colucciello M. Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina 2006;26:239-242.
5. Schlotzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 2002;240: 748-757.
6. Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy in chronic central serous chorioretinopathy. Retina 2003;23:235-237.
7. Canakis C, Livir-Rallatos C, Panayiotis Z, et al. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. Am J Ophthalmol 2003;136: 750-752.
8. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003;23:752-763.
9. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003;23:288-298.
10. Taban M, Boyer DS, Thomas EL, Taban M. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004;137:1073-1080.
11. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 2008;28:85-93.
12. Klais CM, Ober MD, Ciardella AP, Yannuzzi LA. Central serous chorioretinopathy. In: Hinton DR, Schachat AP, Wilkinson CP, Ryan SJ (eds). Retina. 4th ed. London: Elsevier; 1135-1162, 2006.
13. Bennett G. Central serous retinopathy. Br J Ophthalmol 1955; 39:605-618.
14. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63:S1-S139.
15. Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1988; 72:829-834.
16. Faurschou S, Rosenberg T, Nielsen N. Central serous retinop-athy and presenile disciform exudative macular degeneration. Is there an aetiological relationship between these two exudative conditions of the macula? Acta Ophthalmol (Copenh) 1977;55:515-524.
17. Chan WM, Lam DS, Lai TY, et al. Treatment of choroidal neovascularization in central serous chorioretinopathy by pho-todynamic therapy with verteporfin. Am J Ophthalmol 2003; 136:836-845.
18. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Half-dose verteporfin photodynamic therapy for acute central serous cho-rioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 2008;115:1756-1765.
19. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 2006;90:869-874.
20. Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chan-dra S. Experience with nontreatment of central serous choroi-dopathy. Arch Ophthalmol 1974;91:247-250.